Business profile & competitive position
Rollins, Inc. sits in the Industrials sector under the Specialty Business Services industry, but its day-to-day business is best understood as essential pest and wildlife control. Through brands such as Orkin, Critter Control, HomeTeam Pest Defense, and Fox Pest Control, the company provides residential pest control, commercial workplace pest control, and termite and ancillary services to more than two million residential and commercial customers. As of its most recent 10-K, Rollins operates from more than 800 company-owned and franchised locations spread across roughly 70 countries, with 131 domestic and 66 international franchise agreements on the books.
The financial signature of the model is a 13.6% net margin paired with a 37.2% return on equity. The high ROE points to strong capital efficiency, while the mid-teens net margin is consistent with a service business that relies on recurring customer relationships rather than commodity pricing power. That recurring element is real: as of December 31, 2025, approximately 75% of revenue came from recurring services, 10% from ancillary services, and 15% from one-time services. The business is also seasonal by design, with revenue and profit historically higher in the second and third quarters and lower in the first and fourth quarters because pest and termite activity tracks weather patterns.
Financial posture
Rollins currently carries a $17.4 billion market capitalization and trades at a 32.8x P/E multiple. That valuation level is materially above the broad-market average, implying the market has already priced in years of steady growth and margin stability. Profitability supports part of that premium: the 13.6% net margin and 37.2% ROE are both healthy readings for a services-led industrial business, and the 0.74 beta indicates the stock has historically been less volatile than the overall market.
The current technical snapshot adds context but no verdict: the stock is at $36.07, below its 50-day EMA of $40.16, with an RSI of 35.8. Those figures simply describe where the price sits relative to recent momentum; they neither justify nor invalidate the 32.8x P/E on their own.
Strategic priorities & outlook
Rollins’ most recent 10-K frames its operational agenda around four priorities: People First (teammate well-being and employer positioning), Customer Loyalty (improving the customer experience to cut churn and grow faster than the market), Growth Mindset (spotting market changes that create both risks and opportunities), and Operational Efficiency (modernizing operations and optimizing the service model).
Those priorities are supported by the company’s revenue mix and acquisition activity. The 75% recurring-services base gives the customer-loyalty initiative a clear financial hook, because churn reductions flow directly into a high-retention book. Rollins completed 26 acquisitions in 2025 and 94 over the last three years, showing that M&A remains a core lever for geographic and brand expansion. The seasonal profile, meanwhile, means operational efficiency and workforce planning are not just cost items—they affect how well the company can scale during the second and third quarters when pest activity peaks.
Macro & geopolitical exposure
As a Specialty Business Services provider, Rollins’ economics are tied to conditions that affect service demand, labor, regulation, and currency—not heavy manufacturing or raw-materials intensity. At the industry level, key exposures include:
- Housing and commercial real estate activity: Termite inspections and new-home pretreatments generally move with residential construction and home-sale turnover.
- Weather and climate patterns: Pest and termite activity is weather-driven, which affects both revenue seasonality and the frequency of service calls.
- Labor availability and wage inflation: The service model depends on technicians and route density, so wage pressure, fuel costs, and technician turnover directly influence margins.
- Pesticide and environmental regulation: The industry operates under EPA oversight and state-level chemical-use rules, so changes in permissible treatments can alter service protocols and input costs.
- Currency translation: With operations in approximately 70 countries, reported results are exposed to USD cross-rate movements even though the core service is local.
Recent developments
The most recent news flow has mixed tones. On August 27, 2026, Pomerantz Law Firm announced via PR Newswire that it is investigating claims on behalf of Rollins investors, and a separate August 25, 2026 alert via GlobeNewswire carried the same headline. Law-firm investigations are common announcements and do not, by themselves, establish any violation; they are simply part of the current news record.
On the institutional side, August 27, 2026 also brought a defenseworld.net report that Bank of New York Mellon Corp had taken a position in Rollins, and August 24, 2026 brought another defenseworld.net report that B. Metzler seel. Sohn & Co. AG bought 35,688 shares. These filings show fresh institutional interest alongside the legal-investigation headlines.
Looking ahead, Rollins reports again on October 28, 2026, after the close. The current consensus EPS estimate for that release is $0.35.
Earnings behavior & post-earnings drift
Rollins has a weak recent earnings record relative to the official consensus. Over the last eight reported quarters, the company beat estimates only twice, for a beat rate of 29%, and the average earnings surprise was -0.6%. The average five-day price move after those reports was -1.8%, classified as a downward post-earnings drift.
The last four quarters illustrate how quickly misses have been repriced. On October 29, 2025, Rollins reported EPS of $0.35 against an estimate of $0.3281, a +6.7% beat; the stock rose 7.28% the next day and 10.77% over the following five sessions. That was the outlier. On February 11, 2026, EPS of $0.25 missed the $0.2648 estimate by -5.6%, sending the stock down 10.53% the next day and 7.13% over five days. The company bounced back on April 22, 2026, with EPS of $0.24 beating the $0.231 estimate by 3.9%, producing a 3.02% next-day gain but essentially no follow-through (+0.02% over five days). The most recent report on July 22, 2026 showed EPS of $0.32 versus a $0.3357 estimate, a -4.7% miss; the stock fell 9.27% the next day and 10.86% over the following five sessions.
The takeaway from this earnings history is not a directional call but a risk observation: with a 29% beat rate and an average -1.8% five-day drift, the market’s real expectation has become harder to clear than the headline consensus alone suggests, and downside reactions to misses have been larger than upside reactions to beats.
Frequently Asked Questions
What does Rollins actually do, and where does it operate?
Rollins provides pest and wildlife control services, including residential pest control, commercial workplace pest control, and termite and ancillary services. It operates through brands such as Orkin, Critter Control, HomeTeam Pest Defense, and Fox Pest Control from more than 800 company-owned and franchised locations in approximately 70 countries.
How has Rollins stock historically behaved after earnings?
Over the last eight quarters, Rollins beat estimates 29% of the time (2 out of 8), with an average earnings surprise of -0.6% and an average five-day post-earnings drift of -1.8%. The last four quarters show large drawdowns after misses: on July 22, 2026, a -4.7% miss led to a -10.86% five-day drop, and on February 11, 2026, a -5.6% miss led to a -7.13% five-day drop.
What strategic priorities has Rollins highlighted in its 10-K?
Rollins lists four priorities: People First, Customer Loyalty, Growth Mindset, and Operational Efficiency. The 10-K also notes that about 75% of revenue is recurring, the company closed 26 acquisitions in 2025 and 94 over the prior three years, and the business is seasonal with stronger results in the second and third quarters.
For a more complete picture of how institutional analysts currently view Rollins, including detailed ratings, target ranges, and consensus assumptions beyond the headline numbers, readers should examine the full institutional verdict on the company.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-07-22 | $0.32 | $0.3357 | -4.7% | -9.27% | -10.86% |
| 2026-04-22 | $0.24 | $0.231 | +3.9% | +3.02% | +0.02% |
| 2026-02-11 | $0.25 | $0.2648 | -5.6% | -10.53% | -7.13% |
| 2025-10-29 | $0.35 | $0.3281 | +6.7% | +7.28% | +10.77% |
| 2025-07-23 | $0.3 | $0.3027 | -0.9% | - | - |
| 2025-04-23 | $0.22 | $0.2214 | -0.6% | - | - |
Previous ROL editions
Get the institutional verdict on ROL
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the ROL verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.